Albemarle (ALB)
(Delayed Data from NYSE)
$90.25 USD
-1.40 (-1.53%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $90.17 -0.08 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$90.25 USD
-1.40 (-1.53%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $90.17 -0.08 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Zacks News
Charlotte, NC-based Albemarle Corporation is a premier specialty chemicals company with leading positions in attractive end markets globally. It is a leading producer of highly-engineered specialty chemicals geared to meet customer requirements across a bevy of end markets including petroleum refining, consumer electronics, energy storage, construction and automotive.
Albemarle (ALB) Down 1.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Albemarle Corporation (ALB) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Albemarle (ALB) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here's Why You Should Retain Albemarle Stock in Your Portfolio
by Zacks Equity Research
ALB gains on higher lithium volumes, actions to boost its lithium conversion capacity and productivity actions amid headwinds from softer prices.
Investors Heavily Search Albemarle Corporation (ALB): Here is What You Need to Know
by Zacks Equity Research
Albemarle (ALB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here is What to Know Beyond Why Albemarle Corporation (ALB) is a Trending Stock
by Zacks Equity Research
Albemarle (ALB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Albemarle's (ALB) Earnings Miss Estimates in Q2, Revenues Beat
by Zacks Equity Research
While Albemarle (ALB) benefits from higher volumes, lower lithium market pricing weighed on its results in the second quarter.
Albemarle (ALB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Albemarle (ALB) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Albemarle (ALB) Misses Q2 Earnings Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of -92.45% and 2.12%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Is the Options Market Predicting a Spike in Albemarle (ALB) Stock?
by Zacks Equity Research
Investors need to pay close attention to Albemarle (ALB) stock based on the movements in the options market lately.
Albemarle (ALB) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from higher lithium volumes and its cost and productivity actions in the second quarter amid headwinds from softer lithium market prices.
Exploring Analyst Estimates for Albemarle (ALB) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of Albemarle (ALB) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Earnings Preview: Chemours (CC) Q2 Earnings Expected to Decline
by Zacks Equity Research
Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dow Inc. (DOW) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Dow Inc. (DOW) delivered earnings and revenue surprises of -5.56% and 0.41%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Albemarle (ALB) Stock Moves -0.66%: What You Should Know
by Zacks Equity Research
In the most recent trading session, Albemarle (ALB) closed at $90.88, indicating a -0.66% shift from the previous trading day.
Earnings Preview: Albemarle (ALB) Q2 Earnings Expected to Decline
by Zacks Equity Research
Albemarle (ALB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Albemarle Corporation (ALB) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Albemarle (ALB) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here's Why Albemarle (ALB) Fell More Than Broader Market
by Zacks Equity Research
In the most recent trading session, Albemarle (ALB) closed at $93.81, indicating a -1.34% shift from the previous trading day.
Should You Invest in the First Trust Materials AlphaDEX ETF (FXZ)?
by Zacks Equity Research
Sector ETF report for FXZ
New Strong Sell Stocks for July 16th
by Zacks Equity Research
ALB, AAL and AQST have been added to the Zacks Rank #5 (Strong Sell) List on July 16, 2024.
Albemarle (ALB) Rises Higher Than Market: Key Facts
by Zacks Equity Research
Albemarle (ALB) concluded the recent trading session at $99.15, signifying a +0.81% move from its prior day's close.
Albemarle Corporation (ALB) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Albemarle (ALB) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is First Trust Materials AlphaDEX ETF (FXZ) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXZ
Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for NOBL
Implied Volatility Surging for Albemarle (ALB) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Albemarle (ALB) stock based on the movements in the options market lately.
Albemarle Corporation (ALB) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Albemarle (ALB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.